DULAVIGO Trademark

Trademark Overview

On Wednesday, July 12, 2017, a trademark application was filed for DULAVIGO with the United States Patent and Trademark Office. The USPTO has given the DULAVIGO trademark a serial number of 87525914. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 23, 2021. This trademark is owned by Bristol-Myers Squibb Company. The DULAVIGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
dulavigo

General Information

Serial Number87525914
Word MarkDULAVIGO
Filing DateWednesday, July 12, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 23, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 19, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, August 23, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 23, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 11, 2021EXTENSION 5 GRANTED
Friday, January 8, 2021EXTENSION 5 FILED
Friday, January 8, 2021TEAS EXTENSION RECEIVED
Wednesday, July 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 29, 2020EXTENSION 4 GRANTED
Monday, June 29, 2020EXTENSION 4 FILED
Monday, June 29, 2020TEAS EXTENSION RECEIVED
Saturday, January 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2020EXTENSION 3 GRANTED
Thursday, January 9, 2020EXTENSION 3 FILED
Thursday, January 9, 2020TEAS EXTENSION RECEIVED
Thursday, September 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2019EXTENSION 2 GRANTED
Wednesday, July 17, 2019EXTENSION 2 FILED
Wednesday, September 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 25, 2019NOTICE OF REVIVAL - E-MAILED
Wednesday, July 24, 2019EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 24, 2019PETITION TO REVIVE-GRANTED
Wednesday, July 24, 2019TEAS PETITION TO REVIVE RECEIVED
Wednesday, December 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 24, 2018EXTENSION 1 GRANTED
Monday, December 24, 2018EXTENSION 1 FILED
Monday, December 24, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 16, 2018ASSIGNED TO LIE
Thursday, April 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 6, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 6, 2017NON-FINAL ACTION E-MAILED
Friday, October 6, 2017NON-FINAL ACTION WRITTEN
Thursday, October 5, 2017ASSIGNED TO EXAMINER
Wednesday, July 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 15, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

dulavigo diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection